An epidemiologist in Mumbai is conducting a case–control study on the association between oral contraceptive use and venous thromboembolism (VTE) in women aged 25–45 years. During data analysis, she observes that cases (women with VTE) are significantly older than controls (mean age 38 vs. 32 years). Age is known to be independently associated with VTE risk. What is the most appropriate next step?